首页> 美国卫生研究院文献>Membranes >Flux and Passage Enhancement in Hemodialysis by Incorporating Compound Additive into PVDF Polymer Matrix
【2h】

Flux and Passage Enhancement in Hemodialysis by Incorporating Compound Additive into PVDF Polymer Matrix

机译:通过将复合添加剂掺入PVDF聚合物基质中来提高血液透析的通量和通过率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, Polyvinylidene fluoride (PVDF) hollow fiber hemodialysis membranes were prepared by non-solvent induced phase separation (NIPS) with compound addtive. The compound additive was made with polyvinyl pyrrolidone (PVP) and Poly ethylene glycol (PEG). The results showed that the modified PVDF membrane had better separation performance than virgin PVDF membrane. The UF flux of modified PVDF membrane can reach 684 L·h−1·m−2 and lysozyme (LZM) passage is 72.6% while virgin PVDF membrane is 313 L·h−1·m−2 and 53.2%. At the same time, the biocompatibility of PVDF membranes was also improved. Compared with commercial polysulfone hemodialysis membrane (Fresenius F60S membrane), the modified PVDF membrane had better mechanical and separation performance. The stress and tensile elongation of modified PVDF membrane was 0.94 MPa and 352% while Fresenius F60S membrane was 0.79 MPa and 59%. The LZM passage reached 72.6% while Fresenius F60S membrane was 54.4%. It was proven that the modified PVDF membrane showed better hydrophilicity, antithrombogenicity, less BSA adsorption, and lower hemolytic ratio and adhesion of platelets. Water contact angle and BSA adsorption of the modified PVDF membrane are 38° and 45 mg/m2 while Fresenius F60S membrane are 64° and 235 mg/m2. Prothrombin time (PT) and activated partial thromboplastin time (APTT) of the modified PVDF membrane are 56.5 s and 25.8 s while Fresenius F60S membrane is 35.7 s and 16.6 s. However, further biocompatibility evaluation is needed to obtain a more comprehensive conclusion.
机译:在这项研究中,聚偏二氟乙烯(PVDF)中空纤维血液透析膜是通过非溶剂诱导相分离(NIPS)与复合添加剂制备的。用聚乙烯吡咯烷酮(PVP)和聚乙二醇(PEG)制成复合添加剂。结果表明,改性PVDF膜的分离性能优于纯PVDF膜。改性PVDF膜的超滤通量可达到684 L·h -1 ·m -2 ,溶菌酶(LZM)通过率为72.6%,而PVDF膜为313 L·。 h −1 ·m −2 和53.2%。同时,PVDF膜的生物相容性也得到改善。与商用聚砜血液透析膜(Fresenius F60S膜)相比,改性PVDF膜具有更好的机械和分离性能。改性PVDF膜的应力和拉伸伸长率为0.94 MPa和352%,而费森尤斯F60S膜的应力和拉伸伸长率为0.79 MPa和59%。 LZM通道达到72.6%,而费森尤斯F60S膜为54.4%。已经证明,改性的PVDF膜表现出更好的亲水性,抗血栓形成性,更少的BSA吸附以及更低的溶血率和血小板粘附性。改性PVDF膜的水接触角和BSA吸附度分别为38°和45 mg / m 2 ,而费森尤斯F60S膜的吸附角为64°和235 mg / m 2 。改性PVDF膜的凝血酶原时间(PT)和活化的部分凝血活酶时间(APTT)为56.5 s和25.8 s,费森尤斯F60S膜为35.7 s和16.6 s。但是,需要进一步的生物相容性评估以获得更全面的结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号